JP2024505285A - 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法 - Google Patents

薬剤用量ガイダンスに関連するシステム、デバイスおよび方法 Download PDF

Info

Publication number
JP2024505285A
JP2024505285A JP2023547060A JP2023547060A JP2024505285A JP 2024505285 A JP2024505285 A JP 2024505285A JP 2023547060 A JP2023547060 A JP 2023547060A JP 2023547060 A JP2023547060 A JP 2023547060A JP 2024505285 A JP2024505285 A JP 2024505285A
Authority
JP
Japan
Prior art keywords
dose
meal
time
data
guidance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023547060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505285A5 (https=
Inventor
エー ヘイター，ゲイリー
バタチャリヤ，アパラジタ
エス ブディマン，アーウィン
ティー ノヴァク，マシュー
ジン，タイハオ
ビー タウブ，マーク
エム ファーン，ジョナサン
シュィ，ヨンジン
ジュー，カイユエン
コヴィントン，ケンダル
クック，ケリー
ローズ フレー，ジェシカ
ボスコ，ロジーナ
エム チャールズワース，テイラー
パルタサラティ，ヴィシュナヴィ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of JP2024505285A publication Critical patent/JP2024505285A/ja
Publication of JP2024505285A5 publication Critical patent/JP2024505285A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023547060A 2021-02-03 2022-02-02 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法 Pending JP2024505285A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163145131P 2021-02-03 2021-02-03
US63/145,131 2021-02-03
US202163225140P 2021-07-23 2021-07-23
US63/225,140 2021-07-23
US202163237769P 2021-08-27 2021-08-27
US63/237,769 2021-08-27
PCT/US2022/014920 WO2022169856A1 (en) 2021-02-03 2022-02-02 Systems, devices, and methods relating to medication dose guidance

Publications (2)

Publication Number Publication Date
JP2024505285A true JP2024505285A (ja) 2024-02-05
JP2024505285A5 JP2024505285A5 (https=) 2025-02-07

Family

ID=80787465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547060A Pending JP2024505285A (ja) 2021-02-03 2022-02-02 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法

Country Status (5)

Country Link
EP (1) EP4288970A1 (https=)
JP (1) JP2024505285A (https=)
AU (1) AU2022216248A1 (https=)
CA (1) CA3205053A1 (https=)
WO (1) WO2022169856A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025193785A1 (en) * 2024-03-13 2025-09-18 Abbott Diabetes Care Inc. Antihyperglycemic methods and systems

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024252061A1 (en) * 2023-04-11 2025-11-20 WellDoc, Inc. Systems and methods for continuous glucose monitoring outcome predictions
US12251242B1 (en) 2023-10-24 2025-03-18 UpDoc Inc. Voice-based method and system for management of type 2 diabetes
WO2025165721A1 (en) 2024-01-30 2025-08-07 Abbott Diabetes Care Inc. Systems and methods for diabetes management

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019118531A2 (en) * 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
WO2021005552A1 (en) * 2019-07-09 2021-01-14 El Fathi Anas Method and system for determining glucose change in a subject

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
EP1918837A1 (en) * 2006-10-31 2008-05-07 F. Hoffmann-La Roche AG Method for processing a chronological sequence of measurements of a time dependent parameter
ES2881798T3 (es) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos
WO2014018928A1 (en) 2012-07-27 2014-01-30 Abbott Diabetes Care Inc. Medical device applicators
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
CA2895538A1 (en) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US20170185748A1 (en) 2014-03-30 2017-06-29 Abbott Diabetes Care Inc. Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US10806859B2 (en) * 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
WO2018132507A1 (en) 2017-01-11 2018-07-19 Abbott Diabetes Care Inc. Systems, devices, and methods for episode detection and evaluation with visit guides and action plans
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2018152241A1 (en) 2017-02-15 2018-08-23 Abbott Diabetes Care Inc. Systems, devices, and methods for integration of an analyte data reader and medication delivery device
EP3586145A1 (en) 2017-02-21 2020-01-01 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
MX2022001442A (es) 2019-08-02 2022-02-22 Abbott Diabetes Care Inc Sistemas, dispositivos y metodos relacionados con guia de dosis de medicamentos.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019118531A2 (en) * 2017-12-12 2019-06-20 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
WO2021005552A1 (en) * 2019-07-09 2021-01-14 El Fathi Anas Method and system for determining glucose change in a subject

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025193785A1 (en) * 2024-03-13 2025-09-18 Abbott Diabetes Care Inc. Antihyperglycemic methods and systems

Also Published As

Publication number Publication date
CA3205053A1 (en) 2022-08-25
AU2022216248A9 (en) 2025-01-30
WO2022169856A1 (en) 2022-08-11
AU2022216248A1 (en) 2023-07-27
EP4288970A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
US12555660B2 (en) Systems, devices, and methods relating to medication dose guidance
US12424326B2 (en) Systems, devices, and methods for episode detection and evaluation
US12533054B2 (en) Multi-function analyte monitor device and methods of use
US20220249779A1 (en) Systems, devices, and methods relating to medication dose guidance
US20250191740A1 (en) Systems, devices, and methods for episode detection and evaluation with intervention guides, action plans and/or scheduling interfaces
EP3749183B1 (en) System for decision support
JP2024505285A (ja) 薬剤用量ガイダンスに関連するシステム、デバイスおよび方法
US20250342932A1 (en) Systems and methods for medication dosing and titration
CN117099165A (zh) 与药物剂量指导相关的系统、设备及方法
JP2025538349A (ja) 薬剤投与ガイダンスに関するシステム、デバイス、及び方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250130

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260219